Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Potasman

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Plos One|February 12, 2014
Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in IsraelGili Regev-Yochay, Galia Rahav, Klaris Riesenberg, et al.
Scandinavian Journal of Infectious Diseases|May 20, 2009
A retrospective six-year national survey of P. multocida infections in IsraelWilliam Nseir, M Giladi, I Moroz, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionRonen Ben-Ami, Keren Olshtain-Pops, Michal Krieger, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 2017
A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infectionsMichal Stein, Shelly Lipman-Arens, Kfir Oved, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamasesDror Marchaim, Tamar Gottesman, Orna Schwartz, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapyVered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Plos One|March 19, 2015
A novel host-proteome signature for distinguishing between acute bacterial and viral infectionsKfir Oved, Asi Cohen, Olga Boico, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Plos One|February 12, 2014
Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in IsraelGili Regev-Yochay, Galia Rahav, Klaris Riesenberg, et al.
Scandinavian Journal of Infectious Diseases|May 20, 2009
A retrospective six-year national survey of P. multocida infections in IsraelWilliam Nseir, M Giladi, I Moroz, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionRonen Ben-Ami, Keren Olshtain-Pops, Michal Krieger, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 2017
A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infectionsMichal Stein, Shelly Lipman-Arens, Kfir Oved, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamasesDror Marchaim, Tamar Gottesman, Orna Schwartz, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapyVered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Plos One|March 19, 2015
A novel host-proteome signature for distinguishing between acute bacterial and viral infectionsKfir Oved, Asi Cohen, Olga Boico, et al.
Pageof 14